The International Federation for Animal Health (IFAH) is the global representative body of companies engaged in research, development, manufacturing and commercialisation of veterinary medicines, vaccines and other animal health products in both developed and developing countries across the five continents.
IFAH represents both animal health companies (10) and national/regional animal health associations (28). These associations comprise both local small and medium-sized enterprises and international companies. Overall, these companies represent approximately 80% of the global market for animal health products.
IFAH is led by Executive Director Carel du Marchie Sarvaas and is headed up by President Jeff Simmons, President of Elanco Animal Health.
IFAH is an international non-profit organisation registered under Belgian law based in Brussels, Belgium.
To download the latest IFAH Annual Report click here.
Why does IFAH exist?
To foster a greater understanding of animal health;
To promote a predictable, science-based regulatory environment that facilitates the supply of innovative, quality products into a competitive market place. These products contribute to the supply of safe, healthy food, and to high standards of health and welfare for animals and people.
What does IFAH do?
Act as a unified global industry voice in dialogue with major international bodies (OIE, FAO, WHO, Codex, WTO, etc.), governments, animal health stakeholders, food industry partners and consumers.
Encourage and assist the development of predictable science-based regulatory processes and standards where authorisation and approval to market medicines is firmly rooted in a thorough risk-benefit analysis.
Promote international harmonisation of testing requirements for animal health products to facilitate the availability and delivery of new and innovative products worldwide.
Act as a source of information on the benefits of animal health products for animal health and welfare, food and safety and public health.
Actively promote the value of research-based medicines developed to the highest standards and authorised according to the regulatory criteria of quality, safety and efficacy.
Ensure the availability of all classes of veterinary medicines to the benefit of animal health and welfare, and promote their responsible use.
Provide expertise on emerging diseases and fulfil its role as part of the solution to control these diseases in animals.
DOWNLOAD THE FULL FACT SHEET “ABOUT IFAH” INCLUDING: